GeneproDX
PrivateLast Round
Early Funding
Feb 14, 2022
Est. Valuation
$135M
Total Funding Raised
$2.34M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
GeneproDX is a biotechnology company that develops molecular diagnostic tests, including the ThyroidPrint genomic classifier, to aid in the management of indeterminate thyroid nodules.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GeneproDX Comparables
Compare GeneproDX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biocartis | 80% | |
| Sonic Healthcare | 74% | |
| Veracyte | 72% |
GeneproDX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Feb 14, 2022 | ||||
| VC Round | Apr 17, 2018 | ||||
| VC Round | Dec 12, 2017 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 153% MoM.
- Mar 2, 2026
Monthly visitors increased 34% MoM.
GeneproDX Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GeneproDX's valuation, stock price, and market status.
Is GeneproDX a public or private company?
GeneproDX is a private company.
What is the current stock price of GeneproDX?
GeneproDX is a private company, so its shares have no public market price. Caplight tracks GeneproDX's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GeneproDX worth (valuation)?
GeneproDX's valuation is estimated at $135.0M based on funding round data.
Can I buy GeneproDX stock?
GeneproDX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GeneproDX's last funding round?
GeneproDX's most recent funding round was Early Funding on February 14, 2022.
Who are the main investors in GeneproDX?
Investor information for GeneproDX is not publicly disclosed.
Will GeneproDX IPO soon?
No public IPO plans have been announced for GeneproDX.
How can I track GeneproDX secondary market activity?
Caplight tracks bids, offers, and trades in GeneproDX's shares on secondary markets.